---
title: "22100 - R for Bio Data Science"

subtitle: "Group 15 Final project"

author: "Ella Hedeboe (s211253), Lene Christiansen (s163628), Michelle Anker Pihl (s174347) and Mie Guldhammer Andersen (s174343)"

output:
  ioslides_presentation:
    widescreen: true
    smaller: true
---

<!-- <style> -->

<!-- body > slides { -->
<!--     padding: 0; -->
<!--     margin: -35px 0 0 -270px; -->
<!-- } -->

<!-- slides > slide{ -->
<!--     width: 100vw; -->
<!--     height: 100vh; -->
<!--     border-radius: 0; -->
<!-- } -->

<!-- </style> -->

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE)
```

## Presentation outline 

- Introduction to the data set
- Data wrangling
- Augmenting
- Exploratory data analysis
- Modelling the data
- Conclusion

## The dataset

- A clinical trial in Primary Biliary Cirrhosis (PBC) conducted by the Mayo Clinic between 1974 and 1984
- 312 participants all suffering from PBC (varying stages of disease severity)
- Randomized, placebo-controlled clinical trial with the drug D-penicillamine

```{r out.width = "70%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_bar.png")
```

## Variables in the dataset

- Demographic characteristics: age and gender
- Various physiological measurements e.g. serum bilirubin, albumin, protrombin time and presence of edema
- Variables related to the trial: drug/placebo, status (dead/alive), number of follow-up days (until death or end of study participation)


```{r out.width = "100%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_histogram.png")
```

## Mayo risk score 

Formula
$$
\small \text{Mayo risk score} = 0.04 \cdot \text{age in years} + 10.87 \cdot log(\text{serum bilirubin in mg/dL}) \\ \small - 22.53 \cdot log(\text{serum albumin in gm/dL}) + 12.38 \cdot log(\text{prothrombin time in seconds}) \\ \small + 10.86 \cdot \text{edema score}
$$
Formula from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419097/?fbclid=IwAR3A0iZyyxnWdG0mObdwS4U_HBocqfsYkWji50e_1M_2zeCZVFLO8WH3Qyo

<!-- Convert to risk level  -->

<!-- < 8.5: low risk  -->

<!-- \> 8.5 & < 10: medium risk -->

<!-- \> 10: high risk -->

```{r out.width = "60%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_bar_mayo.png")
```
      
## Exploratory data analysis

---
```{r out.width = "60%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_box_age.png")
```

---
```{r out.width = "60%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_step_stage.png")
```

## Clustering

```{r out.width = "100%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_box_fu.png")
```

## Clustering variance
Some notes: 
This represents the variance within the clusters. It decreases as k increases.
If there is a bend, as in the article. The bend indicates that additional clusters beyond have little value. 

## Conclusion

Some notes:
We can conclude that we don't see a positive difference in participants given the drug and participants given placebo. 
Other studies have shown that this drug may course liver problems, which may be the reason our plots show a tendency of people given the placebo living longer.

(Boxplot of follow-up days on x axis, status 1 on y axis and stratified by drug treatment)

```{r out.width = "60%", fig.align = "center"}
knitr::include_graphics("/cloud/project/results/plt_box_fu3.png")
```
